Bcl-2 inhibitor may enhance chemotherapy treatment in patients with prostate cancer

Links shared publicly online about this topic.

1,644
total visits

Bcl-2 inhibitor may enhance chemotherapy treatment in patients with prostate cancer

In trying to better predict a patient's response to chemotherapy for cancer treatment, a team of investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, has identified a way to better manipulate a gene product to cause cancer cells to die.

View full resource at news-medical.net

Tags: Cancer, Chemotherapy, Lung Cancer, Prostate Cancer, Lung, Prostate, Genes, Men's Health